Skip to main content
. 2021 Oct 7;35:20587384211048567. doi: 10.1177/20587384211048567

Table 2.

Blood tests of patients with COVID-19.

All patients (n = 301) Disease severity p value a
Mild (n = 186) Severe (n = 87) Critical (n = 28)
Leucocytes, per μl 5480 (4400–7490) 5300 (4450–7020) 5620 (4280–8360) 7280 (47,80–103,30) 0.065
Neutrophils, per μl 3550 (2760–5000) 3370 (2680–4450) 3720 (2730–5330) 6280 (4070–8120) 0.001
Neutrophil percentage, % 64.1 (57.35–71.91) 62.4 (57.25–67.50) 63.6 (56.6–72.2) 89.95 (83.85–94.15) 0.001
Lymphocytes, per μl 1440 (1020–1820) 1580 (1230–1890) 1190 (890–1690) 785 (530–900) 0.001
Lymphocyte percentage, % 26.2 (19.35–33.30) 27.8 (23.9–34.01) 26.11 (16.45–33.82) 4.65 (3.17–14.3) 0.001
Monocyte, per μl 460 (330–650) 470 (330–620) 500 (390–780) 240 (140–520) 0.001
Monocyte percentage, % 7.9 (6.5–10.15) 7.8 (6.5–10.0) 9.1 (7.52–10.97) 4.25 (2.02–5.51) 0.001
NLR 2.46 (1.77–4.09) 2.1 (1.66–3.04) 2.95 (1.80–4.63) 8.78 (4.63–17.61) 0.001

Data were presented as median (IQR).

aComparison among mild, severe, and critical groups.